From China’s First Approved Stem Cell Therapy to Its First Exosome IND: CytoNiche Enables Dual Industry Firsts
(WorldFrontNews Editorial):- Singapore, Singapore Jul 9, 2026 (Issuewire.com) – China’s Centre for Drug Evaluation (CDE) has officially granted Investigational New Drug (IND) clearance to STX11101 Injection, developed…